KRYS
KRYS
NASDAQ · Biotechnology

Krystal Biotech Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$340.21
-3.22 (-0.94%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target -74.5% upside
Low Target $54.31
Average Target $86.77
High Target $114.95
Current Price $340.21
Current
$340.21
Target
$86.77
$54.31 $86.77 avg $114.95
Scenario Analysis
Bear Case
$54.31
-84.0%
Low target
Base Case
$86.77
-74.5%
Avg target
Bull Case
$114.95
+-66.2%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$356.50
-4.6% from high
52-Week Low
$127.99
+165.8% from low
50-Day SMA
$263.07
+29.3% vs SMA
200-Day SMA
$186.47
+82.4% vs SMA
RSI (14)
38.4
Neutral
Target vs 52W High
$86.77
-75.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%